发明授权
- 专利标题： Compounds effecting glucokinase
- 专利标题（中）： 影响葡萄糖激酶的化合物
-
申请号： US12363899申请日： 2009-02-02
-
公开(公告)号： US07951830B2公开(公告)日： 2011-05-31
- 发明人: Scott Boyd , Peter William Rodney Caulkett , Rodney Brian Hargreaves , Suzanne Saxon Bowker , Roger James , Clifford David Jones , Darren McKerrecher , Michael Howard Block , Craig Johnstone
- 申请人： Scott Boyd , Peter William Rodney Caulkett , Rodney Brian Hargreaves , Suzanne Saxon Bowker , Roger James , Clifford David Jones , Darren McKerrecher , Michael Howard Block , Craig Johnstone
- 申请人地址： SE Sodertalje
- 专利权人： AstraZeneca AB
- 当前专利权人： AstraZeneca AB
- 当前专利权人地址： SE Sodertalje
- 代理机构： Morgan Lewis & Bockius LLP
- 优先权： SE0102764 20010817
- 主分类号： A61K31/425
- IPC分类号： A61K31/425 ; A61K31/415 ; A61K31/496 ; A61K31/433
摘要：
The invention relates to the use of a compound of Formula (I) or a salt, solvate or prodrug thereof, wherein R1, R2, R3, n and m are as described in the specification, in the preparation of a medicament for the treatment or prevention of a disease condition mediated through glucokinase (GLK), such as type 2 diabetes. The invention also relates to a novel group of compounds of Formula (I) and to methods for preparing compounds of Formula (I).
公开/授权文献
- US20090227592A1 COMPOUNDS EFFECTING GLUCOKINASE 公开/授权日：2009-09-10